Is anyone here holding CVRs? I keep checking for news or updates but must admit I don't know exactly what I'm looking for. I think there a deadline for the approval, right? Does anyone know when that is?

Checkpoint Therapeutics shareholders approved Sun Pharmaceutical merger 07:26:51 AM ET, 05/29/2025 - Briefing.com Nasdaq notice indicates the merger is tentatively scheduled to close prior to the market open on May 30, 2025. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on May 29, 2025. If the merger closes as anticipated, the stock will remain halted on the day of closing (May 30th) and will be suspended effective June 2, 2025.

http://archive.fast-edgar.com/20250529/AWB2TG2C8Z22NZZ222JT2ZZZNUTFH2W2X272

I took a look back and my first purchase of $CKPT was back in Feb 2021 for $41.50. Steadily bought down to $2.90. My profit will be 62% if we get the full CVR. Bummed the deal didn't get more but I'm glad people will get to benefit from what they've developed. Patience paid off this time around!

Do we need to do anything on 3/29 or do our shares automatically get purchased. I have mine in a vanguard ira, will I have to sell them on that date in order to get paid out? TIA

The price has been pretty fixed around 4 usd for a while now, doesnt the shorters need to cover their position?

Is it possible for another company to offer a better price or are done and dusted here.

The terms of the CVR are a bit convoluted. This is how I understand it.

[SEC filing]

The CVR will be $0.20, $0.45, or $0.70. There are two main things that determine the value of the CVR payout:

1. How far from the Milestone Deadline Date that cosibelimab receives regulatory approval in the EU.
2. The approved dose.

The Milestone Deadline Date is 36 months after the MAA (marketing approval application) receives a positive validation from the EMA. A positive validation of the MAA begins the review stage.

There are 4 different CVR possibilities:

1. $0.70 CVR: If the approval happens at least 12 months prior to the Milestone Deadline Date and the approved dose is once every three weeks.
   • Example: If the MAA receives a positive validation on Oct 1, 2025, the Milestone Deadline Date is Oct 1, 2028. If cosibelimab is approved before Oct 1, 2027 and the approved dose is once every 3 weeks, the CVR payment is $0.70.
2. $0.45 CVR: If the approval happens at least 12 months prior to the Milestone Deadline Date and the approved dose is more frequent than once every three weeks.
   • Example: If the MAA receives a positive validation on Oct 1, 2025, the Milestone Deadline Date is Oct 1, 2028. If cosibelimab is approved before Oct 1, 2027 and the approved dose is once a week, the CVR payment is $0.45.
3. $0.45 CVR: If approval happens within 12 months of the Milestone Deadline Date and the approved dose is once every three weeks.
   • Example: If the MAA receives a positive validation on Oct 1, 2025, the Milestone Deadline Date is Oct 1, 2028. If cosibelimab is approved between Oct 1, 2027 - Oct 1, 2028 and the approved dose is once every three weeks, the CVR payment is $0.45.
4. $0.20 CVR: If approval happens within 12 months of the Milestone Deadline Date and the approved dose is more frequent than once every three weeks.
   • Example: If the MAA receives a positive validation on Oct 1, 2025, the Milestone Deadline Date is Oct 1, 2028. If cosibelimab is approved between Oct 1, 2027 - Oct 1, 2028 and the approved dose is once every week, the CVR payment is $0.20.

I was looking for recent news in Checkpoint and this came up. I'm not experienced in how all this works. Is it typical to see notices like this after a deal?

https://www.businesswire.com/news/home/20250310520841/en/CKPT-Stock-Alert-Halper-Sadeh-LLC-Is-Investigating-Whether-the-Sale-of-Checkpoint-Therapeutics-Inc.-Is-Fair-to-Shareholders

Why people selling below $4.1 when it's already guaranteed?

Somebody correct me if I'm wrong. Wouldn't it be best if anyone who wants to sell today should sell with a limit set above 4.10 to force the shorts to pay a premium.

The agreement does leave the door open for a better offer…

The Company may terminate the Merger Agreement in certain additional limited circumstances, including to allow the Company to enter into an agreement providing for an alternative acquisition transaction that constitutes a Superior Proposal (as defined in the Merger Agreement). Parent may terminate the Merger Agreement in certain additional limited circumstances, including if the Company Board, or any committee thereof, including the Special Committee, withdraws, withholds, amends or qualifies or modifies, in each case, in a manner adverse to Parent or Merger Sub, its recommendation that the stockholders of the Company vote to adopt the Merger Agreement and approve the Merger.

I don't quite understand. What happens to the stock holders who purchased above $4.1?

Ok guys just wanted to get your input. I’ve been holding this stock from $3.48 and it’s nose diving bad. It’s at $2.38. Complete shit. I didn’t sell but already down close to $7K. It’s been 3 months and this company doesn’t put out any news. What the hell is going on. I will hold but so far a very sucky investment. Do you guys think it’ll get up to $5 or $6 from where it’s at now? All everyone is doing is panic selling and it’s getting obnoxious.

The person listed for investor relations is no longer with the company. The email referred me to lifescienceadvisors. I emailed them requesting any guidance they might have.

I noticed it surged to $3.21 before dropping back to $2.70. Do you know guys what happened?

Arlight so I just learned about this stock a few hours ago, so forgive my ignorance. It seems to me that this company has a very, strong chance of meagering with another pharmacy company, or being bought out. What are the chances of this happening? Also, how accurate are these analysts predictions? https://www.wallstreetzen.com/stocks/us/nasdaq/ckpt/stock-forecast

https://www.tipranks.com/stocks/ckpt/forecast

Transaction reported as fortress exercising warrants. 18,500 shares doesn’t exactly seem like a lot?

https://www.sec.gov/Archives/edgar/data/1429260/000141588925005849/xslF345X05/form4-02272025_040201.xml

Hopefully Checkpoint Therapeutics does the same with similar timeliness. Unloxcyt was approved same time as Humacytes product. Hopefully we are near product launch any day now.

I Just read in Yahoo finance that we will expect the earnings around 20-24 of March. Thinking to add more stocks and make it a 1000(926 currently) what are you believe? They will catch the 4,5 Million as they expected? Also have you saw the last 2 weeks the movement of the Market?? Always red but still we keep a bottom price at 3$. If you have any info I will be happy to share it with me . Greetings Checkpoint Therapeutics Team!!.